Activated Partial Thromboplastin Time (aPTT) Test - Vietnam Registration 2403133ĐKLH/BYT-HTTB
Access comprehensive regulatory information for Activated Partial Thromboplastin Time (aPTT) Test in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2403133ĐKLH/BYT-HTTB and manufactured by Medtronic Plc. The authorized representative in Vietnam is CÔNG TY TNHH MEDTRONIC VIỆT NAM.
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Roche Diagnostics GmbH, and 1 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
2403133ĐKLH/BYT-HTTB
000.00.04.G18-210611-0005
Theo theo phụ lục
Theo phụ lục
Technical Details
Cartridge, LR-ACT; Cartridge, RACT; Cartridge, HR-ACT: Used to determine the activated partial thromboplastin time (aPTT). Used for in vitro diagnosis. Cartridge, HR HTC, Boxed: Used to determine the presence of heparin by the activated partial thromboplastin time (aPTT). Used for in vitro diagnosis. Caution: Due to the specific characteristics of this product, it is important to ensure that heparinase does not inadvertently transfer from the "HR HTC" channel to the "HR" channel of the cartridge.
Dates and Status
Nov 02, 2024